No Excuse for African Leaders in Advancing Continent’s Health Security Through Local Manufacturing 06/08/2024 Maureen Awuor Okoth & Caroline Mbindyo The COVID-19 pandemic underscored the risks of over-reliance on global supply chains for essential health products. Disruptions led to severe delays and shortages of vaccines, therapeutics, and diagnostics, with low- and middle-income countries bearing the brunt. Vaccine inequality starkly highlighted Africa’s vulnerability. Yet this crisis unveiled a unique opportunity for the continent: a chance to […] Continue reading -> India Pledges $85 Million to WHO Traditional Medicine Center 06/08/2024 Disha Shetty India will contribute $85 million over a decade to the World Health Organization’s Global Traditional Medicine Center, the WHO announced. The center, located in the Indian western city of Jamnagar, aims to strengthen the evidence base for traditional medicine and provide data on related policies, practices and public use. The donation is part of a […] Continue reading -> WHO Reaches Deal with Argentinian mRNA Vaccine Developer to Produce a Low-Cost Avian Flu Jab 29/07/2024 Elaine Ruth Fletcher The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading -> Malawi Acts to Overcome COVID-era Setbacks in HPV Vaccination 25/07/2024 Josephine Chinele After experiencing the distress of caring for a loved one with advanced cervical cancer, Edna Maloya vowed to take proactive measures to ensure that her family and friends would be protected. “I was my cousin’s caregiver. I can’t take chances with cervical cancer,” says Maloya, who lives in Blantyre, Malawi’s second largest city. She happily […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> When the South ‘Swings’ Together on Health Equity New Possibilities Emerge 01/07/2024 Elaine Ruth Fletcher While this week’s CARICOM summit in Grenada has been postponed due to Hurricane Beryl, when it does convenes, a key item on the agenda will be the new ‘HeDPAC’ initiative to deepen South-South partnerships to meet shared global health challenges – from pandemic threats to climate change. In remote communities of Guyana, the introduction of […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Gavi Launches Replenishment and Commits to Accelerating African Vaccine Manufacturing 20/06/2024 Zuzanna Stawiska Gavi has already raised $ 2.4 billion of the $9 billion it needs to finance its operations between 2026 and 2030, the global vaccine alliance announced at Global Forum for Vaccine Sovereignty and Innovation in Paris on Thursday. The Forum, co-hosted by France and the Africa Centres for Disease Control and Prevention (Africa CDC), also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
India Pledges $85 Million to WHO Traditional Medicine Center 06/08/2024 Disha Shetty India will contribute $85 million over a decade to the World Health Organization’s Global Traditional Medicine Center, the WHO announced. The center, located in the Indian western city of Jamnagar, aims to strengthen the evidence base for traditional medicine and provide data on related policies, practices and public use. The donation is part of a […] Continue reading -> WHO Reaches Deal with Argentinian mRNA Vaccine Developer to Produce a Low-Cost Avian Flu Jab 29/07/2024 Elaine Ruth Fletcher The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading -> Malawi Acts to Overcome COVID-era Setbacks in HPV Vaccination 25/07/2024 Josephine Chinele After experiencing the distress of caring for a loved one with advanced cervical cancer, Edna Maloya vowed to take proactive measures to ensure that her family and friends would be protected. “I was my cousin’s caregiver. I can’t take chances with cervical cancer,” says Maloya, who lives in Blantyre, Malawi’s second largest city. She happily […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> When the South ‘Swings’ Together on Health Equity New Possibilities Emerge 01/07/2024 Elaine Ruth Fletcher While this week’s CARICOM summit in Grenada has been postponed due to Hurricane Beryl, when it does convenes, a key item on the agenda will be the new ‘HeDPAC’ initiative to deepen South-South partnerships to meet shared global health challenges – from pandemic threats to climate change. In remote communities of Guyana, the introduction of […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Gavi Launches Replenishment and Commits to Accelerating African Vaccine Manufacturing 20/06/2024 Zuzanna Stawiska Gavi has already raised $ 2.4 billion of the $9 billion it needs to finance its operations between 2026 and 2030, the global vaccine alliance announced at Global Forum for Vaccine Sovereignty and Innovation in Paris on Thursday. The Forum, co-hosted by France and the Africa Centres for Disease Control and Prevention (Africa CDC), also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Reaches Deal with Argentinian mRNA Vaccine Developer to Produce a Low-Cost Avian Flu Jab 29/07/2024 Elaine Ruth Fletcher The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading -> Malawi Acts to Overcome COVID-era Setbacks in HPV Vaccination 25/07/2024 Josephine Chinele After experiencing the distress of caring for a loved one with advanced cervical cancer, Edna Maloya vowed to take proactive measures to ensure that her family and friends would be protected. “I was my cousin’s caregiver. I can’t take chances with cervical cancer,” says Maloya, who lives in Blantyre, Malawi’s second largest city. She happily […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> When the South ‘Swings’ Together on Health Equity New Possibilities Emerge 01/07/2024 Elaine Ruth Fletcher While this week’s CARICOM summit in Grenada has been postponed due to Hurricane Beryl, when it does convenes, a key item on the agenda will be the new ‘HeDPAC’ initiative to deepen South-South partnerships to meet shared global health challenges – from pandemic threats to climate change. In remote communities of Guyana, the introduction of […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Gavi Launches Replenishment and Commits to Accelerating African Vaccine Manufacturing 20/06/2024 Zuzanna Stawiska Gavi has already raised $ 2.4 billion of the $9 billion it needs to finance its operations between 2026 and 2030, the global vaccine alliance announced at Global Forum for Vaccine Sovereignty and Innovation in Paris on Thursday. The Forum, co-hosted by France and the Africa Centres for Disease Control and Prevention (Africa CDC), also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Malawi Acts to Overcome COVID-era Setbacks in HPV Vaccination 25/07/2024 Josephine Chinele After experiencing the distress of caring for a loved one with advanced cervical cancer, Edna Maloya vowed to take proactive measures to ensure that her family and friends would be protected. “I was my cousin’s caregiver. I can’t take chances with cervical cancer,” says Maloya, who lives in Blantyre, Malawi’s second largest city. She happily […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> When the South ‘Swings’ Together on Health Equity New Possibilities Emerge 01/07/2024 Elaine Ruth Fletcher While this week’s CARICOM summit in Grenada has been postponed due to Hurricane Beryl, when it does convenes, a key item on the agenda will be the new ‘HeDPAC’ initiative to deepen South-South partnerships to meet shared global health challenges – from pandemic threats to climate change. In remote communities of Guyana, the introduction of […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Gavi Launches Replenishment and Commits to Accelerating African Vaccine Manufacturing 20/06/2024 Zuzanna Stawiska Gavi has already raised $ 2.4 billion of the $9 billion it needs to finance its operations between 2026 and 2030, the global vaccine alliance announced at Global Forum for Vaccine Sovereignty and Innovation in Paris on Thursday. The Forum, co-hosted by France and the Africa Centres for Disease Control and Prevention (Africa CDC), also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> When the South ‘Swings’ Together on Health Equity New Possibilities Emerge 01/07/2024 Elaine Ruth Fletcher While this week’s CARICOM summit in Grenada has been postponed due to Hurricane Beryl, when it does convenes, a key item on the agenda will be the new ‘HeDPAC’ initiative to deepen South-South partnerships to meet shared global health challenges – from pandemic threats to climate change. In remote communities of Guyana, the introduction of […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Gavi Launches Replenishment and Commits to Accelerating African Vaccine Manufacturing 20/06/2024 Zuzanna Stawiska Gavi has already raised $ 2.4 billion of the $9 billion it needs to finance its operations between 2026 and 2030, the global vaccine alliance announced at Global Forum for Vaccine Sovereignty and Innovation in Paris on Thursday. The Forum, co-hosted by France and the Africa Centres for Disease Control and Prevention (Africa CDC), also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> When the South ‘Swings’ Together on Health Equity New Possibilities Emerge 01/07/2024 Elaine Ruth Fletcher While this week’s CARICOM summit in Grenada has been postponed due to Hurricane Beryl, when it does convenes, a key item on the agenda will be the new ‘HeDPAC’ initiative to deepen South-South partnerships to meet shared global health challenges – from pandemic threats to climate change. In remote communities of Guyana, the introduction of […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Gavi Launches Replenishment and Commits to Accelerating African Vaccine Manufacturing 20/06/2024 Zuzanna Stawiska Gavi has already raised $ 2.4 billion of the $9 billion it needs to finance its operations between 2026 and 2030, the global vaccine alliance announced at Global Forum for Vaccine Sovereignty and Innovation in Paris on Thursday. The Forum, co-hosted by France and the Africa Centres for Disease Control and Prevention (Africa CDC), also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> When the South ‘Swings’ Together on Health Equity New Possibilities Emerge 01/07/2024 Elaine Ruth Fletcher While this week’s CARICOM summit in Grenada has been postponed due to Hurricane Beryl, when it does convenes, a key item on the agenda will be the new ‘HeDPAC’ initiative to deepen South-South partnerships to meet shared global health challenges – from pandemic threats to climate change. In remote communities of Guyana, the introduction of […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Gavi Launches Replenishment and Commits to Accelerating African Vaccine Manufacturing 20/06/2024 Zuzanna Stawiska Gavi has already raised $ 2.4 billion of the $9 billion it needs to finance its operations between 2026 and 2030, the global vaccine alliance announced at Global Forum for Vaccine Sovereignty and Innovation in Paris on Thursday. The Forum, co-hosted by France and the Africa Centres for Disease Control and Prevention (Africa CDC), also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
When the South ‘Swings’ Together on Health Equity New Possibilities Emerge 01/07/2024 Elaine Ruth Fletcher While this week’s CARICOM summit in Grenada has been postponed due to Hurricane Beryl, when it does convenes, a key item on the agenda will be the new ‘HeDPAC’ initiative to deepen South-South partnerships to meet shared global health challenges – from pandemic threats to climate change. In remote communities of Guyana, the introduction of […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Gavi Launches Replenishment and Commits to Accelerating African Vaccine Manufacturing 20/06/2024 Zuzanna Stawiska Gavi has already raised $ 2.4 billion of the $9 billion it needs to finance its operations between 2026 and 2030, the global vaccine alliance announced at Global Forum for Vaccine Sovereignty and Innovation in Paris on Thursday. The Forum, co-hosted by France and the Africa Centres for Disease Control and Prevention (Africa CDC), also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Gavi Launches Replenishment and Commits to Accelerating African Vaccine Manufacturing 20/06/2024 Zuzanna Stawiska Gavi has already raised $ 2.4 billion of the $9 billion it needs to finance its operations between 2026 and 2030, the global vaccine alliance announced at Global Forum for Vaccine Sovereignty and Innovation in Paris on Thursday. The Forum, co-hosted by France and the Africa Centres for Disease Control and Prevention (Africa CDC), also […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Gavi Launches Replenishment and Commits to Accelerating African Vaccine Manufacturing 20/06/2024 Zuzanna Stawiska Gavi has already raised $ 2.4 billion of the $9 billion it needs to finance its operations between 2026 and 2030, the global vaccine alliance announced at Global Forum for Vaccine Sovereignty and Innovation in Paris on Thursday. The Forum, co-hosted by France and the Africa Centres for Disease Control and Prevention (Africa CDC), also […] Continue reading -> Posts navigation Older postsNewer posts